Zick Suzanna Maria, Czuhajewski Christina, Fouladbakhsh Judith M, Greenlee Heather, Harris Richard Edmund, Henry Norah Lynn, Jolly Shruti, Khabir Tohfa, Perlmutter Jane, Remington Tami, Snyder Detrick, Spratke Lisa, Zebrack Brad, Zettell Erin, Benn Rita
1 Department of Family Medicine, University of Michigan , Ann Arbor, Michigan.
2 Department of Nutritional Sciences, University of Michigan , Ann Arbor, Michigan.
J Altern Complement Med. 2018 Sep/Oct;24(9-10):1018-1022. doi: 10.1089/acm.2018.0184.
Oncology providers are often confronted by patients who use complementary or alternative therapies, but have limited knowledge or confidence on how to advise patients on appropriate use. Despite this, there are few opportunities for oncology providers to learn about complementary or alternative therapies, while at the same time there is a high demand for integrative oncology (IO) training. To address a gap in IO educational opportunities, and particularly for nonphysicians, we created the Integrative Oncology Scholars (IOS) Program. The program's goal is to train 100 IO leaders and facilitate partnerships between them and complementary practitioners.
Four iterations of a year-long National Cancer Institute-funded educational program that combines in-person team-based learning and eLearning to teach the evidence, application, and philosophy supporting IO.
In-person sessions take place at the University of Michigan, and eLearning is implemented using a Canvas website (Instructure, Inc., Salt Lake City, UT).
Nurses, social workers, physician assistants, psychologists, physicians, pharmacists, and physical/occupational therapists with active oncology practices. Educational intervention: Four cohorts of 25 oncology providers per year will learn the evidence base for complementary and alternative approaches to a wide number of oncology topics, including symptom control, dietary supplements commonly used by cancer patients, diet, and the utility of specific integrative approaches for common oncology side-effects such as fatigue.
A mixed methods approach will be used to evaluate overall IOS Program progress and individual scholar's impact on IO research, education, and clinical endeavors.
The first cohort of 25 IOS has been recruited and their education will begin in Summer 2018. Scholars come from 13 states and represent 23 different healthcare systems.
The IOS Program has the potential to increase the number of trained IO providers, educators, and researchers in the United States.
肿瘤学医疗服务提供者经常会遇到使用补充或替代疗法的患者，但他们在就如何合理使用这些疗法为患者提供建议方面，知识有限且信心不足。尽管如此，肿瘤学医疗服务提供者了解补充或替代疗法的机会很少，而与此同时，对综合肿瘤学（IO）培训的需求却很高。为了填补IO教育机会方面的空白，特别是针对非医生群体，我们创建了综合肿瘤学学者（IOS）项目。该项目的目标是培训100名IO领域的领导者，并促进他们与补充疗法从业者之间的合作关系。
一项为期一年、由美国国立癌症研究所资助的教育项目，共进行了四轮，该项目将基于团队的面对面学习与电子学习相结合，以传授支持IO的证据、应用方法及理念。
面对面课程在密歇根大学举行，电子学习通过Canvas网站（Instructure公司，犹他州盐湖城）实施。
从事肿瘤学实际工作的护士、社会工作者、医师助理、心理学家、医生、药剂师以及物理治疗师/职业治疗师。教育干预：每年有四个小组，每组25名肿瘤学医疗服务提供者，他们将学习针对众多肿瘤学主题的补充和替代方法的证据基础，这些主题包括症状控制、癌症患者常用的膳食补充剂、饮食，以及针对疲劳等常见肿瘤学副作用的特定综合方法的效用。
将采用混合方法来评估IOS项目的总体进展以及个别学者对IO研究、教育和临床工作的影响。
首批25名IOS学者已招募完成，他们的培训将于2018年夏季开始。学者们来自13个州，代表23个不同的医疗系统。
IOS项目有潜力增加美国经过培训的IO医疗服务提供者、教育工作者和研究人员的数量。
